From Mass to Molecules: PM2.5 Constituents and Cardiopulmonary Admissions in Makkah
Highlights
- BC and Pb in PM2.5 are the strongest predictors of acute cardiopulmonary admissions in Makkah, implicating combustion emissions as key drivers.
- Crustal elements exhibit minimal health effects despite high levels, indicating that PM2.5 toxicity depends on composition rather than mass.
- Effects are greater in females and adults aged 45–65; cardiovascular impacts peak at lag 1–2 and persist to lag 4, while respiratory effects occur at lags 0−1.
- Associations for BC and Pb persist—and strengthen—after excluding hypertension cases, confirming effects beyond blood pressure pathways and underscoring the need to control combustion sources in high-pilgrimage urban settings.
Abstract
1. Introduction
2. Methods
2.1. Study Design
2.2. Study Area
2.3. Sampling
2.4. Health Data and Disease Classification
2.5. Statistical Analysis
3. Results
4. Discussion
5. Conclusions
Supplementary Materials
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Acknowledgments
Conflicts of Interest
References
- World Health Organization. Burden of Disease from Household Air Pollution for 2012: Summary of Results; WHO: Geneva, Switzerland, 2014; Available online: https://swisstph.ch/fileadmin/user_upload/SwissTPH/Institute/Ludok/WHO2014_BurdenOfDiseaseFromAirPollution2012.pdf (accessed on 22 March 2026).
- Alzahrani, M.S.; Alharthi, Y.S.; Aljamal, J.K.; Alarfaj, A.A.; Vennu, V.; Noweir, M.D. National and Regional Rates of Chronic Diseases and All-Cause Mortality in Saudi Arabia—Analysis of the 2018 Household Health Survey Data. Int. J. Environ. Res. Public Health 2023, 20, 5254. [Google Scholar] [CrossRef] [Scilit]
- Nayebare, S.R.; Aburizaiza, O.S.; Siddique, A.; Carpenter, D.O.; Zeb, J.; Aburizaiza, A.J.; Pantea, C.; Hussain, M.M.; Khwaja, H.A. Association of fine particulate air pollution with cardiopulmonary morbidity in Western Coast of Saudi Arabia. Saudi Med. J. 2017, 38, 905–912. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Health Effects Institute. State of Global Air 2025: A Report on Air Pollution and Its Role in the World’s Leading Causes of Death; Health Effects Institute: Boston, MA, USA, 2025; Available online: https://www.stateofglobalair.org (accessed on 8 November 2025).
- Kelly, F.J.; Fussell, J.C. Size, source and chemical composition as determinants of toxicity attributable to ambient particulate matter. Atmos. Environ. 2012, 60, 504–526. [Google Scholar] [CrossRef] [Scilit]
- Weichenthal, S.; Lavigne, E.; Traub, A.; Umbrio, D.; You, H.; Pollitt, K.; Shin, T.; Kulka, R.; Stieb, D.M.; Korsiak, J.; et al. Association of Sulfur, Transition Metals, and the Oxidative Potential of Outdoor PM2.5 with Acute Cardiovascular Events: A Case-Crossover Study of Canadian Adults. Environ. Health Perspect. 2021, 129, 107005. [Google Scholar] [CrossRef] [Scilit]
- Wu, D.; Li, C.; Shi, Y.; Han, J.; Lu, Y.; Yilihamu, Y.; Zheng, Y.; Zhang, L. Effect of PM2.5 and its constituents on hospital admissions for cardiometabolic multimorbidity in Urumqi, China. Sci. Rep. 2025, 15, 6394. [Google Scholar] [CrossRef] [Scilit]
- Chen, L.-C.; Maciejczyk, P.; Thurston, G.D. Metals and air pollution. In Handbook on the Toxicology of Metals; Elsevier: Amsterdam, The Netherlands, 2022; pp. 137–182. [Google Scholar] [CrossRef] [Scilit]
- Wang, L.; Wang, C.; Liu, T.; Xuan, H.; Li, X.; Shi, X.; Dai, F.; Chen, J.; Li, D.; Xu, T. Association of low-level lead exposure with all-cause and cardiovascular disease mortality in US adults with hypertension: Evidence from the National Health and Nutrition Examination Survey 2003–2010. Arch. Public Health 2023, 81, 146. [Google Scholar] [CrossRef] [Scilit]
- Guo, C.; Liu, A.; Liu, H.; Wu, J. Air pollution and the number of daily visits of hypertension in northern china: A time-series analysis on generalized additive model. Sci. Rep. 2025, 15, 24483. [Google Scholar] [CrossRef] [Scilit]
- Jo, Y.S.; Lim, M.N.; Han, Y.J.; Kim, W.J. Epidemiological study of PM2.5 and risk of COPD-related hospital visits in association with particle constituents in Chuncheon, Korea. Int. J. Chronic Obstr. Pulm. Dis. 2018, 13, 299–307. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Wang, Y.; Wu, Y.; Zheng, F.; Zhang, T.; Wang, M.; Huang, L.; Fan, X.; Chen, J.; Xiao, N. Health threat of PM2.5-bound trace elements exposure on asthma hospital admission: A time-stratified case-crossover study. Environ. Int. 2022, 170, 107604. [Google Scholar] [CrossRef] [Scilit]
- Ikhsan, M. Air Pollution and Respiratory Diseases During The Hajj Season in The Holy City of Makkah. Respir. Sci. 2022, 2, 124–131. [Google Scholar] [CrossRef] [Scilit]
- Nayebare, S.R.; Aburizaiza, O.S.; Siddique, A.; Carpenter, D.O.; Hussain, M.M.; Zeb, J.; Aburiziza, A.J.; Khwaja, H.A. Ambient air quality in the holy city of Makkah: A source apportionment with elemental enrichment factors (EFs) and factor analysis (PMF). Environ. Pollut. 2018, 243, 1791–1801. [Google Scholar] [CrossRef] [Scilit]
- Thangavel, P.; Park, D.; Lee, Y.-C. Recent Insights into Particulate Matter (PM2.5)-Mediated Toxicity in Humans: An Overview. Int. J. Environ. Res. Public Health 2022, 19, 7511. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Alsufayan, Y.; Nayebare, S.R.; Aburizaiza, O.S.; Siddique, A.; Carpenter, D.O.; Hussain, M.M.; Zeb, J.; Aburiziza, A.J.; Khwaja, H.A. Seasonal trends and source apportionment of water-soluble inorganic ions in PM2.5 in Makkah, Saudi Arabia. Sci. Total Environ. 2025, 997, 180152. [Google Scholar] [CrossRef] [Scilit]
- Nayebare, S.R. Fine Particulate Air Pollution in Saudi Arabia—Implications for Cardiopulmonary Morbidity. Doctoral Dissertation, State University of New York at Albany, Albany, NY, USA, 2016. Available online: https://www.proquest.com/openview/28281453309e8189cf4d4ebd06ce676f/1?pq-origsite=gscholar&cbl=18750 (accessed on 8 November 2025).
- Wang, Q.; Liu, S. The Effects and Pathogenesis of PM2.5 and Its Components on Chronic Obstructive Pulmonary Disease. Int. J. Chronic Obstr. Pulm. Dis. 2023, 18, 493–506. [Google Scholar] [CrossRef] [Scilit]
- Zhu, X.; Qian, Y.; Li, X.; Li, Z.; Guo, C.; Wang, Z.; Wei, Y. Research status of black carbon aerosol: Definitions and impacts on health, climate and other welfare. Res. Environ. Sci. 2021, 34, 2536–2546. (In Chinese) [Google Scholar] [CrossRef]
- Chen, H.; Oliver, B.G.; Pant, A.; Olivera, A.; Poronnik, P.; Pollock, C.A.; Saad, S. Effects of air pollution on human health—Mechanistic evidence suggested by in vitro and in vivo modelling. Environ. Res. 2022, 212, 113378. [Google Scholar] [CrossRef] [Scilit]
- Zhang, F.; Guo, C.-G.; Yang, C.; Wang, F.; Wang, W.; Zhang, L. Exposure–Response Associations of Ambient Heavy Metal and Persistent Organic Pollutant with All-Cause and Cause-Specific Mortality: A Prospective Cohort Study. Environ. Health 2025, 3, 493–503. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Zhou, B.; Perel, P.; Mensah, G.A.; Ezzati, M. Global epidemiology, health burden and effective interventions for elevated blood pressure and hypertension. Nat. Rev. Cardiol. 2021, 18, 785–802. [Google Scholar] [CrossRef] [Scilit]
- Milibari, A.A.; Hanigan, I.C.; Badri, H.M.; Khan, W.A.; Rumchev, K. The impact of air pollution on cardiovascular and respiratory mortality in Makkah, Saudi Arabia, during the Hajj cultural events and COVID-19 outbreak. Air Qual. Atmos. Health 2025, 18, 3255–3265. [Google Scholar] [CrossRef] [Scilit]
- Dang, P.; Tang, M.; Fan, H.; Hao, J. Chronic lead exposure and burden of cardiovascular disease during 1990–2019: A systematic analysis of the global burden of disease study. Front. Cardiovasc. Med. 2024, 11, 1367681. [Google Scholar] [CrossRef] [Scilit]
- Feyisetan, O.A.; Mustapha, S.; Ndamitso, M.M.; Salau, R.B.; Salihu, S.O.; Abulude, F.O.; Mathew, J.T. Spatio-seasonal variability and source inference of PM2.5 in Abuja, Nigeria: Implications for urban air quality policy. J. Chem. Allied Sci. 2025, 1, 23–35. [Google Scholar] [CrossRef]
- Tsao, Y.-H.; Huang, J.-J.; Hung, C.-H.; Chang, S.-H.; Hsieh, H.-M. Trends in PM2.5 and mortality risks in an industrial District of Taiwan: A 12-year analysis. Int. J. Environ. Health Res. 2025, 1–12. [Google Scholar] [CrossRef] [Scilit]
- You, X.; Cao, X.; Guo, Y.; Wang, D.; Qiu, W.; Zhou, C.; Zhou, M.; Chen, W.; Zhang, X. Associations between short-term PM2.5 exposure and daily hospital admissions for circulatory system diseases in Ganzhou, China: A time series study. Front. Public Health 2023, 11, 1134516. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Nkansah, F.K.; Durosimi Belford, E.J.; Hogarh, J.N.; Anim, A.K. Assessment of ambient air quality and health risks from vehicular emissions in urban Ghana: A case study of Winneba. J. Air Pollut. Health 2025, 10, 19–36. [Google Scholar] [CrossRef] [Scilit]
- Grivas, G.; Stavroulas, I.; Liakakou, E.; Kaskaoutis, D.G.; Bougiatioti, A.; Paraskevopoulou, D.; Gerasopoulos, E.; Mihalopoulos, N. Measuring the spatial variability of black carbon in Athens during wintertime. Air Qual. Atmos. Health 2019, 12, 1405–1417. [Google Scholar] [CrossRef] [Scilit]
- Shakya, K.M.; Peltier, R.E. Non-sulfate sulfur in fine aerosols across the United States: Insight for organosulfate prevalence. Atmos. Environ. 2015, 100, 159–166. [Google Scholar] [CrossRef] [Scilit]
- Pinkerton, K.E.; Harbaugh, M.; Han, M.K.; Jourdan Le Saux, C.; Van Winkle, L.S.; Martin, W.J.; Kosgei, R.J.; Carter, E.J.; Sitkin, N.; Smiley-Jewell, S.M.; et al. Women and Lung Disease. Sex Differences and Global Health Disparities. Am. J. Respir. Crit. Care Med. 2015, 192, 11–16. [Google Scholar] [CrossRef] [Scilit]
- Höhn, A.; Gampe, J.; Lindahl-Jacobsen, R.; Christensen, K.; Oksuyzan, A. Do men avoid seeking medical advice? A register-based analysis of gender-specific changes in primary healthcare use after first hospitalisation at ages 60+ in Denmark. J. Epidemiol. Community Health 2020, 74, 573–579. [Google Scholar] [CrossRef] [Scilit]
- Almaqhawi, A.; Alsayil, S.; Al Qadhib, M.; Alkhoufi, A.; Alkhalaf, A.; Al Khowildi, Z. Patient’s Perspective on Factors Affecting Health-Seeking Behavior in Al-Ahsa, Saudi Arabia. Cureus 2022, 14, e30078. [Google Scholar] [CrossRef] [Scilit]
- LaKind, J.S.; Burns, C.J.; Johnson, G.T.; Lange, S.S. Epidemiology for risk assessment: The US Environmental Protection Agency quality considerations and the Matrix. Hyg. Environ. Health Adv. 2023, 6, 100059. [Google Scholar] [CrossRef] [Scilit]






| Component | Alharam (Primary Site) | Al-Hajj | Alshoqiyah | Herra Hospital | Ar Rusayfah |
|---|---|---|---|---|---|
| PM2.5 | 113 (458; 83.8) | 59.6 (254; 31.3) | 59.3 (361; 26.8) | 63.7 (342; 29.3) | 75.9 (285; 39.0) |
| Crustal Material | |||||
| Al | 4.47 (15.6; 3.84) | 2.85 (9.28; 2.32) | 2.63 (14.3; 1.89) | 1.78 (7.76; 1.22) | 3.47 (10.3; 2.05) |
| Ca | 11.4 (43.1; 12.5) | 3.81 (12.3; 2.91) | 4.12 (13.7; 3.20) | 3.09 (10.9; 2.41) | 5.02 (15.4; 3.82) |
| K | 1.31 (5.93; 1.18) | 0.220 (0.640; 0.090) | 0.130 (0.370; 0.100) | 0.270 (1.20; 0.120) | 0.230 (0.440; 0.110) |
| Fe | 5.99 (32.0; 6.18) | 2.71 (17.2; 2.07) | 3.58 (31.3; 2.53) | 2.01 (9.06; 1.18) | 4.90 (21.3; 3.38) |
| Mg | 1.19 (4.92; 1.17) | 0.180 (0.430; 0.130) | 0.170 (0.540; 0.130) | 0.190 (1.11; 0.160) | 0.270 (0.830; 0.130) |
| Ti | 0.520 (2.51; 0.520) | 0.050 (0.120; 0.040) | 0.060 (0.190; 0.050) | 0.050 (0.150; 0.040) | 0.070 (0.220; 0.060) |
| Si | 12.1 (45.7; 13.0) | 5.54 (24.4; 4.62) | 48.6 (271; 35.5) | 4.52 (21.7; 2.79) | 10.1 (32.4; 5.78) |
| Sea Spray | |||||
| Na | 0.960 (2.09; 0.520) | 0.690 (2.05; 0.590) | 0.710 (1.83; 0.660) | 0.970 (10.6; 0.920) | 0.890 (1.83; 0.460) |
| Cl | 0.850 (2.75; 1.20) | 0.230 (1.28; 0.210) | 0.210 (0.970; 0.260) | 0.630 (15.9; 0.270) | 0.550 (4.50; 0.490) |
| Fossil-Fuel Combustion | |||||
| Ni | 0.024 (0.093; 0.020) | 0.011 (0.051; 0.005) | 0.013 (0.072; 0.006) | 0.009 (0.022; 0.005) | 0.016 (0.063; 0.011) |
| S | 4.44 (11.7; 2.73) | 8.91 (27.1; 7.07) | 9.35 (34.1; 7.23) | 10.1 (24.3; 7.08) | 2.91 (7.50; 1.77) |
| NO3− | 4.00 (15.0; 2.66) | 1.54 (3.49; 1.00) | 1.71 (9.86; 1.16) | 1.88 (5.82; 1.89) | 4.11 (13.7; 3.06) |
| NH4+ | 1.50 (7.00; 2.31) | 1.74 (6.60; 1.82) | 2.08 (7.47; 2.79) | 1.73 (6.70; 1.19) | 1.31 (4.09; 1.23) |
| BC | 2.85 (8.10; 1.80) | 1.70 (3.50; 1.05) | 1.28 (5.00; 1.00) | 1.95 (5.00; 1.25) | 1.46 (3.20; 0.900) |
| Industrial Emissions | |||||
| Cr | 0.022 (0.095; 0.020) | 0.011 (0.056; 0.006) | 0.012 (0.090; 0.008) | 0.008 (0.028; 0.005) | 0.015 (0.062; 0.012) |
| Mn | 0.130 (0.680; 0.120) | 0.056 (0.303; 0.045) | 0.076 (0.630; 0.059) | 0.043 (0.161; 0.030) | 0.104 (0.450; 0.073) |
| Cu | 0.035 (0.110; 0.027) | 0.026 (0.084; 0.011) | 0.027 (0.127; 0.013) | 0.012 (0.046; 0.008) | 0.020 (0.093; 0.015) |
| Zn | 0.130 (0.530; 0.100) | 0.043 (0.157; 0.019) | 0.042 (0.171; 0.021) | 0.029 (0.082; 0.016) | 0.047 (0.243; 0.025) |
| Pb | 0.065 (1.20; 0.050) | 0.058 (0.952; 0.043) | 0.092 (2.84; 0.018) | 0.030 (0.285; 0.022) | 0.081 (0.905; 0.067) |
| Characteristic | Cardiovascular (n = 300) | Pulmonary (n = 284) | Total (n = 584) |
|---|---|---|---|
| Sex | |||
| Female, n (%) | 170 (56.7%) | 130 (45.8%) | 300 (51.4%) |
| Male, n (%) | 130 (43.3%) | 154 (54.2%) | 284 (48.6%) |
| Age group | |||
| <45 years, n (%) | 42 (14.0%) | 159 (56.0%) | 201 (34.4%) |
| 45–65 years, n (%) | 150 (50.0%) | 100 (35.2%) | 250 (42.8%) |
| >65 years, n (%) | 108 (36.0%) | 25 (8.8%) | 133 (22.8%) |
| Visit type | |||
| ER/OP visits, n (%) | 273 (91.0%) | 216 (76.1%) | 489 (83.7%) |
| Inpatient visits, n (%) | 27 (9.0%) | 68 (23.9%) | 95 (16.3%) |
| Disease Type, n (%) | |||
| COPD | 105 | 17.98% | |
| Bronchopneumonia | 179 | 30.65% | |
| Unstable angina | 66 | 11.3% | |
| Hypertension | 233 | 39.89% | |
| Other | 1 | 0.17% |
| PM2.5 Constituent | Disease Type | Outcome | Single Model aRR (95% CI) | Multiple Model aRR (95% CI) |
|---|---|---|---|---|
| Al | CVD | ER-OP | 1.03 (0.95–1.12) | 1.00 (0.91–1.10) |
| Inpatient | 1.08 (0.93–1.26) | 1.04 (0.89–1.22) | ||
| Pulmonary | ER-OP | 1.06 (0.97–1.17) | 1.02 (0.93–1.12) | |
| Inpatient | 1.11 (0.96–1.29) | 1.07 (0.91–1.26) | ||
| BC | CVD | ER-OP | 1.18 (1.08–1.29) | 1.12 (1.01–1.25) |
| Inpatient | 1.25 (1.07–1.46) | 1.19 (1.02–1.38) | ||
| Pulmonary | ER-OP | 1.14 (1.04–1.25) | 1.09 (0.99–1.20) | |
| Inpatient | 1.20 (1.03–1.40) | 1.15 (1.00–1.33) | ||
| Ni | CVD | ER-OP | 1.24 (0.89–1.72) | 1.019 (1.008–1.030) |
| Inpatient | 1.017 (1.007–1.027) | 1.028 (1.017–1.039) | ||
| Pulmonary | ER-OP | 1.15 (1.09–1.76) | 1.37 (1.09–1.48) | |
| Inpatient | 1.36 (1.14–1.59) | 1.02 (0.91–1.15) | ||
| NO3− | CVD | ER-OP | 1.06 (0.98–1.14) | 1.04 (0.95–1.13) |
| Inpatient | 1.12 (0.97–1.29) | 1.07 (0.91–1.24) | ||
| Pulmonary | ER-OP | 1.07 (0.99–1.16) | 1.03 (0.94–1.13) | |
| Inpatient | 1.10 (0.95–1.27) | 1.05 (0.90–1.22) | ||
| S | CVD | ER-OP | 1.15 (1.06–1.24) | 1.10 (1.00–1.21) |
| Inpatient | 1.22 (1.06–1.40) | 1.17 (1.01–1.36) | ||
| Pulmonary | ER-OP | 1.13 (1.03–1.24) | 1.09 (0.99–1.20) | |
| Inpatient | 1.20 (1.03–1.39) | 1.15 (0.99–1.33) | ||
| Fe | CVD | ER-OP | 1.11 (1.01–1.23) | 1.07 (0.96–1.19) |
| Inpatient | 1.18 (1.02–1.37) | 1.12 (0.96–1.32) | ||
| Pulmonary | ER-OP | 1.10 (1.00–1.21) | 1.06 (0.95–1.18) | |
| Inpatient | 1.15 (0.99–1.34) | 1.10 (0.94–1.29) | ||
| Mg | CVD | ER-OP | 1.14 (1.04–1.25) | 1.10 (1.00–1.21) |
| Inpatient | 1.21 (1.05–1.39) | 1.16 (1.01–1.34) | ||
| Pulmonary | ER-OP | 1.12 (1.02–1.23) | 1.07 (0.97–1.19) | |
| Inpatient | 1.18 (1.01–1.37) | 1.13 (0.98–1.31) | ||
| Ti | CVD | ER-OP | 1.20 (1.11–1.30) | 0.83 (0.65–1.09) |
| Inpatient | 1.28 (1.12–1.46) | 0.92 (0.81–1.09) | ||
| Pulmonary | ER-OP | 1.16 (1.06–1.26) | 1.03 (0.91–1.14) | |
| Inpatient | 1.24 (1.09–1.41) | 1.08 (0.89–1.10) | ||
| Pb | CVD | ER-OP | 1.16 (1.05–1.28) | 1.11 (0.99–1.23) |
| Inpatient | 1.21 (1.06–1.38) | 1.15 (1.01–1.32) | ||
| Pulmonary | ER-OP | 1.13 (1.02–1.25) | 1.09 (0.98–1.21) | |
| Inpatient | 1.18 (1.03–1.35) | 1.12 (0.98–1.29) | ||
| NH4+ | CVD | ER-OP | 1.10 (1.02–1.18) | 1.07 (0.99–1.15) |
| Inpatient | 1.12 (0.98–1.28) | 1.09 (0.95–1.25) | ||
| Pulmonary | ER-OP | 0.87 (0.63–1.13) | 0.98 (0.74–1.21) | |
| Inpatient | 1.16 (1.05–1.32) | 1.00 (0.83–1.12) |
| PM2.5 Constituent | Outcome | Single Model aRR (95% CI) | Multiple Model aRR (95% CI) |
|---|---|---|---|
| Al | ER-OP | 1.12 (0.78–1.63) | 1.02 (0.67–1.55) |
| Inpatient | 1.38 (0.71–2.76) | 1.21 (0.60–2.48) | |
| BC | ER-OP | 2.12 (1.44–3.17) | 1.68 (1.07–2.74) |
| Inpatient | 2.70 (1.34–5.42) | 2.20 (1.10–4.26) | |
| Ni | ER-OP | 2.65 (0.61–11.40) | 1.10 (1.05–1.15) |
| Inpatient | 1.09 (1.04–1.14) | 1.14 (1.09–1.20) | |
| NO3− | ER-OP | 1.32 (0.92–1.83) | 1.20 (0.80–1.75) |
| Inpatient | 1.68 (0.88–3.15) | 1.36 (0.67–2.65) | |
| S | ER-OP | 1.89 (1.31–2.64) | 1.55 (1.01–2.36) |
| Inpatient | 2.46 (1.32–4.54) | 2.04 (1.07–3.98) | |
| Fe | ER-OP | 1.62 (1.06–2.55) | 1.36 (0.84–2.20) |
| Inpatient | 2.12 (1.10–4.11) | 1.67 (0.84–3.49) | |
| Mg | ER-OP | 1.82 (1.20–2.74) | 1.55 (1.01–2.36) |
| Inpatient | 2.38 (1.26–4.40) | 1.95 (1.06–3.73) | |
| Ti | ER-OP | 2.28 (1.61–3.26) | 0.45 (0.16–1.50) |
| Inpatient | 3.04 (1.67–5.46) | 0.71 (0.40–1.49) | |
| Pb | ER-OP | 1.95 (1.25–3.04) | 1.62 (0.97–2.55) |
| Inpatient | 2.36 (1.31–4.25) | 1.88 (1.06–3.48) | |
| NH4+ | ER-OP | 1.55 (1.10–2.12) | 1.36 (0.97–1.89) |
| Inpatient | 1.68 (0.92–3.05) | 1.48 (0.80–2.73) |
| PM2.5 Constituent | Outcome | Visit Type | Model Specification (Co-Pollutants Included) | aRR (95% CI) | p-Value |
|---|---|---|---|---|---|
| BC | CVD | ER/OP | +Pb + S + Ni + Fe | 1.12 (1.01–1.25) | 0.03 |
| CVD | Inpatient | +Pb + S + Ni + Fe | 1.19 (1.02–1.38) | 0.03 | |
| Pulmonary | ER/OP | +Pb + S + Ni + Fe | 1.09 (0.99–1.20) | 0.08 | |
| Pulmonary | Inpatient | +Pb + S + Ni + Fe | 1.15 (1.00–1.33) | 0.05 | |
| Pb | CVD | ER/OP | +BC + S + Ni + Fe | 1.11 (0.99–1.23) | 0.07 |
| CVD | Inpatient | +BC + S + Ni + Fe | 1.15 (1.01–1.32) | 0.04 | |
| Pulmonary | ER/OP | +BC + S + Ni + Fe | 1.09 (0.98–1.21) | 0.11 | |
| Pulmonary | Inpatient | +BC + S + Ni + Fe | 1.12 (0.98–1.29) | 0.09 | |
| Ni | CVD | ER/OP | +BC + S + Pb | 1.019 (1.008–1.030) | <0.01 |
| CVD | Inpatient | +BC + S + Pb | 1.028 (1.017–1.039) | <0.01 | |
| Pulmonary | ER/OP | +BC + S + Pb | 1.37 (1.09–1.48) | <0.01 | |
| Pulmonary | Inpatient | +BC + S + Pb | 1.02 (0.91–1.15) | 0.73 | |
| S | CVD | ER/OP | +BC + Pb + Ni + Fe | 1.10 (1.00–1.21) | 0.05 |
| CVD | Inpatient | +BC + Pb + Ni + Fe | 1.17 (1.01–1.36) | 0.04 | |
| Pulmonary | ER/OP | +BC + Pb + Ni + Fe | 1.09 (0.99–1.20) | 0.08 | |
| Pulmonary | Inpatient | +BC + Pb + Ni + Fe | 1.15 (0.99–1.33) | 0.06 | |
| Fe | CVD | ER/OP | +BC + Pb + S + Mg | 1.07 (0.96–1.19) | 0.22 |
| CVD | Inpatient | +BC + Pb + S + Mg | 1.12 (0.96–1.32) | 0.16 | |
| Pulmonary | ER/OP | +BC + Pb + S + Mg | 1.06 (0.95–1.18) | 0.29 | |
| Pulmonary | Inpatient | +BC + Pb + S + Mg | 1.10 (0.94–1.29) | 0.23 | |
| Mg | CVD | ER/OP | +BC + Fe + Ti | 1.10 (1.00–1.21) | 0.05 |
| CVD | Inpatient | +BC + Fe + Ti | 1.16 (1.01–1.34) | 0.04 | |
| Pulmonary | ER/OP | +BC + Fe + Ti | 1.07 (0.97–1.19) | 0.18 | |
| Pulmonary | Inpatient | +BC + Fe + Ti | 1.13 (0.98–1.31) | 0.09 | |
| Ti | CVD | ER/OP | +BC + Fe + Mg | 0.83 (0.65–1.09) | 0.18 |
| CVD | Inpatient | +BC + Fe + Mg | 0.92 (0.81–1.09) | 0.34 | |
| Pulmonary | ER/OP | +BC + Fe + Mg | 1.03 (0.91–1.14) | 0.62 | |
| Pulmonary | Inpatient | +BC + Fe + Mg | 1.08 (0.89–1.10) | 0.44 | |
| Al | CVD | ER/OP | +Si + Ca + Fe | 1.00 (0.91–1.10) | 0.98 |
| CVD | Inpatient | +Si + Ca + Fe | 1.04 (0.89–1.22) | 0.62 | |
| Pulmonary | ER/OP | +Si + Ca + Fe | 1.02 (0.93–1.12) | 0.69 | |
| Pulmonary | Inpatient | +Si + Ca + Fe | 1.07 (0.91–1.26) | 0.42 | |
| NO3− | CVD | ER/OP | +NH4+ + S | 1.04 (0.95–1.13) | 0.42 |
| CVD | Inpatient | +NH4+ + S | 1.07 (0.91–1.24) | 0.41 | |
| Pulmonary | ER/OP | +NH4+ + S | 1.03 (0.94–1.13) | 0.51 | |
| Pulmonary | Inpatient | +NH4+ + S | 1.05 (0.90–1.22) | 0.52 | |
| NH4+ | CVD | ER/OP | +NO3− + S | 1.07 (0.99–1.15) | 0.09 |
| CVD | Inpatient | +NO3− + S | 1.09 (0.95–1.25) | 0.22 | |
| Pulmonary | ER/OP | +NO3− + S | 0.98 (0.74–1.21) | 0.86 | |
| Pulmonary | Inpatient | +NO3− + S | 1.00 (0.83–1.12) | 0.98 |
| Study (Year) | Location | Mean PM2.5 (µg/m3) | Key Constituents Assessed | Main Findings | Effect Size (aRR per IQR) |
|---|---|---|---|---|---|
| Present study (2026) | Makkah, Saudi Arabia | 113.6 | BC, Pb, Ni, S, Fe, Crustals | BC and Pb strongest predictors; crustal elements null | BC: 1.18–1.25; Pb: 1.16–1.21 |
| Nayebare et al. (2017) [3] | Jeddah, Saudi Arabia | 68.5 | BC, SO42−, NO3−, NH4+ | BC and secondary aerosols associated with cardiopulmonary admissions | BC: 1.12–1.18 |
| Milibari et al. (2025) [23] | Makkah, Saudi Arabia | 95.2 | PM2.5 mass only | PM2.5 mass associated with CVD mortality during Hajj | PM2.5: 1.08–1.15 |
| Wu et al. (2025) [7] | Urumqi, China | 89.4 | BC, Pb, Ni, Cr, As | BC and metals associated with cardiometabolic admissions | BC: 1.14–1.22; Pb: 1.09–1.16 |
| You et al. (2023) [27] | Ganzhou, China | 48.6 | Pb, Ni, Cr, As | Pb and Ni increased circulatory admissions | Pb: 1.12–1.19; Ni: 1.10–1.15 |
| Feyisetan et al. (2025) [25] | Abuja, Nigeria | 78.3 | BC, S, heavy metals | Traffic and industrial components, not dust, drove health risk | BC: 1.15–1.20 |
| Grivas et al. (2019) [29] | Athens, Greece | 28.4 | BC, S, Ni | BC and S from traffic and fuel combustion linked to morbidity | BC: 1.06–1.12 |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2026 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license.
Share and Cite
Alsufayan, Y.; Nayebare, S.R.; Aburizaiza, O.S.; Siddique, A.; Hussain, M.M.; Aburizaiza, A.J.; Carpenter, D.O.; Khwaja, H.A. From Mass to Molecules: PM2.5 Constituents and Cardiopulmonary Admissions in Makkah. Toxics 2026, 14, 449. https://doi.org/10.3390/toxics14050449
Alsufayan Y, Nayebare SR, Aburizaiza OS, Siddique A, Hussain MM, Aburizaiza AJ, Carpenter DO, Khwaja HA. From Mass to Molecules: PM2.5 Constituents and Cardiopulmonary Admissions in Makkah. Toxics. 2026; 14(5):449. https://doi.org/10.3390/toxics14050449
Chicago/Turabian StyleAlsufayan, Yousef, Shedrack R. Nayebare, Omar S. Aburizaiza, Azhar Siddique, Mirza M. Hussain, Abdullah J. Aburizaiza, David O. Carpenter, and Haider A. Khwaja. 2026. "From Mass to Molecules: PM2.5 Constituents and Cardiopulmonary Admissions in Makkah" Toxics 14, no. 5: 449. https://doi.org/10.3390/toxics14050449
APA StyleAlsufayan, Y., Nayebare, S. R., Aburizaiza, O. S., Siddique, A., Hussain, M. M., Aburizaiza, A. J., Carpenter, D. O., & Khwaja, H. A. (2026). From Mass to Molecules: PM2.5 Constituents and Cardiopulmonary Admissions in Makkah. Toxics, 14(5), 449. https://doi.org/10.3390/toxics14050449

